【レポートの概要（一部）】
Table of Contents
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Geriatric Medicine Industry Outlook
3.1 Market segmentation
3.2 Geriatric Medicine Market dynamics
3.3 Market driver analysis
3.4 Market restraint analysis
3.5 Key Opportunities Prioritized
3.6 Industry analysis – Porter’s
3.7 Geriatric Medicine Market PESTEL Analysis
Chapter 4 Geriatric Medicine Therapeutics Outlook
4.1 Geriatric Medicine market share by therapeutics, 2015 & 2024
4.2 Analgesics
4.2.1 Analgesics market estimates and forecasts, 2013 – 2024 (USD Billion)
4.3 Antihypertensive
4.3.1 Antihypertensive market estimates and forecasts, 2013 – 2024 (USD Billion)
4.4 Statins
4.4.1 Statins market estimates and forecasts, 2013 – 2024 (USD Billion)
4.5 Antidiabetic
4.5.1 Antidiabetic market estimates and forecasts, 2013 – 2024 (USD Billion)
4.6 PPI
4.6.1 PPI market estimates and forecasts, 2013 – 2024 (USD Billion)
4.7 Anticoagulant
4.7.1 Anticoagulant market estimates and forecasts, 2013 – 2024 (USD Billion)
4.8 Antipsychotic
4.8.1 Antipsychotic market estimates and forecasts, 2013 – 2024 (USD Billion)
4.9 Others
4.9.1 Others market estimates and forecasts, 2013 – 2024 (USD Billion)
Chapter 5 Geriatric Medicine Condition Outlook
5.1 Geriatric Medicine Market share by condition, 2015 & 2024
5.2 Cardiovascular
5.2.1 Cardiovascular market estimates and forecasts, 2013 – 2024 (USD Billion)
5.3 Arthritis
5.3.1 Arthritis market estimates and forecasts, 2013 – 2024 (USD Billion)
5.4 Neurological
5.4.1 Neurological market estimates and forecasts, 2013 – 2024 (USD Billion)
5.5 Cancer
5.5.1 Cancer market estimates and forecasts, 2013 – 2024 (USD Billion)
5.6 Osteoporosis
5.6.1 Osteoporosis market estimates and forecasts, 2013 – 2024 (USD Billion)
5.7 Respiratory
5.7.1 Respiratory market estimates and forecasts, 2013 – 2024 (USD Billion)
5.8 Others
5.8.1 Others market estimates and forecasts, 2013 – 2024 (USD Billion)
Chapter 6 Geriatric Medicine Regional Outlook
6.1 Geriatric Medicine Market share, by region, 2015 & 2024
6.2 North America
6.2.1 Geriatric Medicine Market estimates and forecasts, by therapeutics, 2013 – 2024 (USD Billion)
6.2.1.1 U.S. market estimates and forecasts
6.2.1.2 Canada market estimates and forecasts
6.2.2 Geriatric Medicine Market estimates and forecasts, by condition, 2013 – 2024 (USD Billion)
6.2.2.1 U.S. market estimates and forecasts
6.2.2.2 Canada market estimates and forecasts
6.3 Europe
6.3.1 Geriatric Medicine Market estimates and forecasts, by therapeutics, 2013 – 2024 (USD Billion)
6.3.1.1 UK market estimates and forecasts
6.3.1.2 Germany market estimates and forecasts
6.3.2 Geriatric Medicine Market estimates and forecasts, by condition, 2013 – 2024 (USD Billion)
6.3.2.1 UK market estimates and forecasts
6.3.2.2 Germany market estimates and forecasts
6.4 Asia Pacific
6.4.1 Geriatric Medicine Market estimates and forecasts, by therapeutics, 2013 – 2024 (USD Billion)
6.4.1.1 Japan market estimates and forecasts
6.4.1.2 China market estimates and forecasts
6.4.2 Geriatric Medicine Market estimates and forecasts, by condition, 2013 – 2024 (USD Billion)
6.4.2.1 Japan market estimates and forecasts
6.4.2.2 China market estimates and forecasts
6.5 Latin America
6.5.1 Geriatric Medicine Market estimates and forecasts, by therapeutics, 2013 – 2024 (USD Billion)
6.5.1.1 Brazil market estimates and forecasts
6.5.1.2 Mexico market estimates and forecasts
6.5.2 Geriatric Medicine Market estimates and forecasts, by condition, 2013 – 2024 (USD Billion)
6.5.2.1 Brazil market estimates and forecasts
6.5.2.2 Mexico market estimates and forecasts
6.6 MEA
6.6.1 Geriatric Medicine Market estimates and forecasts, by therapeutics, 2013 – 2024 (USD Billion)
6.6.1.1 South Africa market estimates and forecasts
6.6.2 Geriatric Medicine Market estimates and forecasts, by condition, 2013 – 2024 (USD Billion)
6.6.2.1 South Africa market estimates and forecasts
Chapter 7 Competitive Landscape
7.1 GlaxoSmithKline Plc.
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Abbott Laboratories, Inc.
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 Boehringer Ingelheim GmbH
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 AstraZeneca plc
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Bristol-Myers Squibb Company
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 Eli Lilly and Company
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Merck & Company Inc.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Novartis AG
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Pfizer, Inc.
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
7.10 Sanofi S.A.
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives
【レポート販売概要】
■ タイトル：老年医学の世界市場分析：分類別（鎮痛薬、抗高血圧薬、スタチン、抗糖尿病薬、プロトンポンプ阻害薬、抗凝固薬、抗精神病薬、抗うつ薬）、治療条件別（心臓血管、関節炎、神経学、がん、骨粗鬆症、呼吸器）、セグメント予測■ 英文：Geriatric Medicine Market Analysis By Therapeutic Category (Analgesics, Antihypertensives, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, Antidepressant), by Therapeutic Condition (Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory) And Segment Forecasts To 2024
■ 発行日：2016年6月12日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707362
■ 調査対象地域：グローバル
- パスタのグローバル市場（～2019）The industry report Global Pasta Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for pasta in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, …
- アレルギー性鼻炎治療薬の世界市場予測：抗ヒスタミン剤、コルチコステロイド、免疫療法、ワクチンAllergic Rhinitis drugs - new study showing you trends, partnerships, and predicted revenues Where is the market for allergic rhinitis drugs heading? What are the commercial prospects for this market? Visiongain’s new report shows you potential revenues and other trends to 2025, discussing data, opportunities and prospects. Our 326 page report provides 273 tables, charts, and graphs. Discover the …
- DRaaS(Disaster Recovery as a Service)の世界市場2015-2019About Disaster Recovery as a Service Disaster recovery as a service refers to services that offer business continuity by enabling data backup, recovery, and retrieval. It is one of the fastest growing segment in the cloud-based recovery model under infrastructure as a service market. It can help enterprises to record business critical data files during the occurrence of natural calamities such as …
- MEK阻害剤の世界市場：メキニスト、コテリック、メクトビGlobal MEK Inhibitors Market 2019-2023: About the market MEK is a drug that inhibits the mitogen-activated extracellular signal-regulated kinase. Technavio’s MEK inhibitors market analysis considers sale from MEKINIST, COTELLIC, and MEKTOVI. Our analysis also considers the MEK inhibitors in Asia, Europe, North America, and ROW. In 2018, the MEKINIST segment had a significant share, and this trend …
- Effexor (大うつ病性障害)：医薬品市場予測及び分析（～2023）Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for …
- Iclusig (Chronic Myeloid Leukemia)：市場予測と分析（～2022）Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL fusion protein. The stage of CML is classified …
- アレイ器具の世界市場：DNAマイクロアレイ、プロテインマイクロアレイAbout array instruments An array is the technology used in laboratories that quantitatively and simultaneously monitors the expression of thousand genes. The high-throughput approach of microarrays help locate mutations in genotype, measure and detect gene expressions at the mRNA or at the protein level, and locate chromosomal expressions. They work on basic aspects such as hybridization, coupling …
- 世界のトップ10高成長複合材料市場“The top 10 high growth composite materials market is projected to grow at a CAGR of 7.04% during forecast period”The top 10 high growth composite materials market is projected to reach USD 69.50 billion in 2015 to USD 105.26 billion by 2021, at a CAGR of 7.04% between 2016 and 2021. The major factor expected to boost the growth of the market is high demand for top 10 composite materials from the …
- インタラクティブプロジェクターの世界市場予測（～2022）：デジタル光処理（DLP）、液晶表示（LCD）、反射型液晶素子（LCoS）The interactive projector market is expected to reach USD 2601.6 Million by 2022, at a CAGR of 21.5% between 2016 and 2022. The growth of this market is propelled by increasing adoption of interactive projectors in education segment, low cost of interactive projectors compared to interactive whiteboards, significant advantages of interactive projectors over conventional projectors. Increasing dema …
- パスワード管理ソフトウェアの世界市場2015-2019About password management Password management is a software solution that helps to store and organize passwords. It is widely used by the end-users to secure, audit, manage, and monitor all activities associated with privileged accounts. This solution helps to secure the privileged users’ accounts that exists on network appliance, server, and desktop operating system of an IT infrastructure. Passw …
- 細胞治療の世界市場Pharmaceutical companies are actively looking for different modalities which could help in generating more revenues by competing with existing products. Traditional therapeutic have modest safety and efficacy levels and newer options are required to overcome their shortcomings. In this quest, they have focused upon cell therapy which holds both pharmacological and commercialization potential. Thei …
- 経カテーテル塞栓術および閉塞デバイスの世界市場2019-2023About this market The high demand for non-coils embolization devices is one of the critical reasons that will drive the transcatheter embolization and occlusion devices market. Non-coils embolization devices such as liquid embolic are preferred by surgeons as it support minimally invasive surgery. Flow diverting devices and embolization particles are some of the non-coils embolization devices that …
- China Pharmaceutical Market Outlook – Government Incentives, Healthcare Reform and a Rapidly Ageing Population Provide Strong Stimulus for GrowthChina Pharmaceutical Market Outlook - Government Incentives, Healthcare Reform and a Rapidly Ageing Population Provide Strong Stimulus for Growth Summary GBI Research’s new report: “China Pharmaceutical Market Outlook - Government Incentives, Healthcare Reform and a Rapidly Ageing Population Provide Strong Stimulus for Growth” provides in-depth analysis of the trends, issues and challenges facing …
- 中国の移動補助・運搬機器市場見通し（～2021）China Mobility Aids and Transportation Equipment Market Outlook to 2021 Summary GlobalData’s new report, "China Mobility Aids and Transportation Equipment Market Outlook to 2021", provides key market data on the China Mobility Aids and Transportation Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segme …
- 世界のメシチレン市場2015The Global Mesitylene Industry Report 2015 is a professional and in-depth study on the current state of the Mesitylene industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Mesitylene market analysis is provided for the international markets including development trends, competitive landscape analysis, …
